CD44 and endometrial cancer: The associations between altered levels of circulating CD44, TGM2 and EpCAM and hematologic prognostic parameters reflecting a systemic immune and inflammatory response, such as neutrophil/lymphocyte ratio (NLR), monocyte count, and platelet/lymphocyte ratio (PLR) were also evaluated in patients with endometriosis and with endometrial cancer and are presented in the Additional file 7: Table S6 (S7).